Remove 2024 Remove Medicare Remove Prescription Drug Pricing
article thumbnail

Medicare Prescription Payment Plan (M3P) Implementation: Key Considerations for Part D Plan Sponsors and PBMs

Innovaare Compliance

The upcoming Medicare Prescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach to prescription drug coverage. Price Transparency: Increased transparency in drug pricing to enable beneficiaries to make informed decisions.

article thumbnail

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Jane Sarashon

While the digital health stakeholder community is convening this week at VIVE in Los Angeles to share innovations in health tech, NABIP has assembled health insurance leaders in Washington, DC, for the 2024 Capital Conference to focus on major health reform issues that are top-of-mind for health care payors — which in today’s U.S.

ACA 118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023

Health Law Advisor

To advance these efforts, CMS established a Medicare Drug Rebate and Negotiations Group dedicated to the IRA and set forth the agency’s intended overarching timeline to implement the various IRA provisions, such as the Medicare Drug Price Negotiation Program and the Part D redesign.

article thumbnail

Medicare Prescription Payment Plan (M3P) Implementation: Key Considerations for Part D Plan Sponsors and PBMs

Innovaare Compliance

The upcoming Medicare Prescription Payment Plan (M3P), set to launch in January 2025, marks a significant shift in Medicare’s approach to prescription drug coverage. Price Transparency: Increased transparency in drug pricing to enable beneficiaries to make informed decisions.

article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Healthcare Law Blog

The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]

article thumbnail

What’s Expected to Drive Up Health Plan Costs in 2025: GLP-1s, Behavioral Health, and Inflationary Pressures for Hospitals and Doctors – PwC’s Behind the Numbers 2025

Jane Sarashon

Bureau of Labor Statistics had good news for American consumers long-facing inflation for household spending over the past couple of years, announcing on July 11, 2024, that the general consumer price index (CPI) fell, lowering real prices for people buying airline tickets, used cars and trucks, communication, and petrol to fill auto tanks.

Doctors 59
article thumbnail

How Will the “New” Health Economy Fare in a Macro-Economic Downturn?

Health Populi

Add into this picture a CCS Insight analyst’s forecast last week that Apple could enter the health insurance market in 2024. health care system not seen since the 1968 creation of Medicare, coupled with decreased reimbursement due to health care reform. Walmart) to do so, as well.